期刊文献+

罗格列酮治疗非酒精性脂肪肝的实验研究 被引量:14

The effect of rosiglitazone on non-alcoholic fatty liver in experimental rats
暂未订购
导出
摘要 目的研究罗格列酮对非酒精性脂肪肝(NAFL)的作用,并探讨胰岛素抵抗(IR)与NAFL的关系。方法以喂食高脂饲料建立大鼠NAFL模型,将其随机分为罗格列酮治疗组和模型对照组,治疗4周后处死动物,观察肝脏组织学变化,并测定肝功能、FBG、FIns、血脂、瘦素、脂联素等指标。结果罗格列酮组与模型对照组相比,肝脂肪变性明显好转,肝功能明显改善,丙氨酸氨基转移酶为54±19U/L与101±24U/L,门冬氨酸氨基转移酶为151±37U/L与198±48U/L,碱性磷酸酶为87±16U/L与115±39U/L(P<0·01);脂联素水平显著上升,瘦素水平明显减低;胰岛素抵抗指数(HOMA-IR)明显减低,分别为6·9±1·8和12·0±1·2(P<0·01);血清TG、TC、LDL-C水平显著降低(P<0·01)。结论IR在NAFL的发生发展过程中可能发挥重要作用,罗格列酮可有效逆转动物模型的NAFL。 Objective To investigate the effect of rosiglitazone on non-alcoholic fatty liver (NAFL) and to explore the relationship between insulin resistance and NAFL. Methods Animal model of NAFI. was established by feeding Sprague-Dawley rats a high-fat diet for 8 weeks. The model rats were then randomized into rosiglitazone-treated and untreated groups. The animals were sacrificed after being treated with rosiglitazone or vehicle for 4 weeks. The histological changes of liver were examined, and liver function, fasting plasma glucose, fasting serum insulin, serum lipid profile, leptin, and adiponectin were measured. Results As compared with untreated group, hepatic steatosis and liver function were significantly improved in rosiglitazone-treated group. Alanine aminotrans ferase (ALT) was 54±19 U/L vs 101±24 U/L, aspartic acid aminotransferase (AST) 151±37 U/L vs 198±48 U/L, and alkaline phosphatase (ALP) 87±16 U/L vs 115±39 U/L, respectively (P〈 0.01). Serum adiponectin level was higher, and serum leptin level and insulin resistance index (HO- MA-IR) were lower in rosiglitazone-treated group than in untreated group. HOMA-IR was 6.9±1.8 vs 12.0±1.2 (P〈0.01). Serum triglyceride, total cholesterol and low density lipoprotein-cholesterol level were significantly decreased in rosiglitazone-treated group as compared with untreated group (P〈 0.01). Conclusions Insulin resistance might play important role in the pathogenesis of NAFL. Rosiglitazone effectively reverses NAFL in animal model.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2006年第4期277-280,共4页 Chinese Journal of Diabetes
关键词 罗格列酮 脂肪肝 非酒精性 胰岛素抵抗 Rosiglitazone Fatty liver, non-alcoholic Insulin resistence
  • 相关文献

参考文献10

  • 1Bacon BR,Farahvash MJ,Janney CG,et al.Nonalcoholic steatohepatitis:an expanded clinical entity.Gastroenterology,1994,107:1103-1109.
  • 2宋冰.肥胖与脂肪肝[J].日本医学介绍,1995,16(10):440-442. 被引量:30
  • 3钟岚,范建高,王国良,吴伟清,史祺.肥胖、高脂血症性脂肪性肝炎模型的建立[J].实验动物科学与管理,2000,17(2):16-20. 被引量:139
  • 4范小芬,邓银泉.非酒精性脂肪肝患者的胰岛素抵抗状态[J].浙江医学,2002,24(5):267-269. 被引量:23
  • 5Day CP,James OF.Steatohepatitis:a tale of two "hits".J.Gastroenterology,1998,114:842-845.
  • 6Willner IR,Waters B,Patil SR,et al.Ninety patients with nonalcoholic steatohepatitis:insulin resistance,familial tendency,and severity of disease.Am J Gastroenterol,2001,96:2957-2961.
  • 7Katoh SH,Hata S,Matsushima M.Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy-a randomized controlled trial.Metabolism,2001,50:414-417.
  • 8Caldwell SH,Hespenheide EE,Redick JA,et al.A pilot study of a thiazolidinedione,troglitazone in nonalcoholic steatohepatitis.Am J Gastroenterd,2001,96:519-525.
  • 9Iwata M,Haruta T,Usui I,et al.Pioglitazone ameliorates tumor necrosis factor a induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferactor-activated receptor g.Diabetes,2001,50:1083-1092.
  • 10陈晓平,杨文英,卜石,萧建中,刘雪莉,王娜,赵文惠.罗格列酮和二甲双胍对高脂饲养造成的胰岛素抵抗的影响[J].中华内科杂志,2004,43(4):280-283. 被引量:65

二级参考文献20

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2127
  • 2杨文英,邢小燕,林红,马晓华,胡英华,李光伟,潘孝仁.高甘油三酯血症是非胰岛素依赖型糖尿病发病的危险因素──432例非糖尿病人群六年前瞻性观察[J].中华内科杂志,1995,34(9):583-586. 被引量:143
  • 3邓银泉,余永谱,李夏玉,朱肖鸿,韦思金.脂肪肝的患病与相关因素调查分析[J].浙江医学,1996,18(4):254-255. 被引量:8
  • 4胰岛β细胞功能研究协作组.正常人馒头餐试验过程中血糖、胰岛素、C肽的观察[J].中华医学杂志,1982,62(11):643-643.
  • 5Storlien LH, James DE, Burleigh KM, et al. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol, 1986, 251(5 Pt 1):E576-E583.
  • 6McGarry JD. Banting lecture 2001:dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes,2002,51:7-18.
  • 7Lee Y,Hirose H, Ohneda M,et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A, 1994,91: 10878-10882.
  • 8Randle PJ,Garland PB,Hales CN, et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1963,1: 785-789.
  • 9Boden G, Chen X, Ruiz J, et al. Mechanism of fatty acid-induced inhibition of glucose uptake. J Clin Invest, 1994, 93: 2438-2446.
  • 10Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and huperinsulinemia. J Clin Endocrinol Metab, 2001,86:1930-1935.

共引文献251

同被引文献129

引证文献14

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部